Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 3
108
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

LRP8, modulated by miR-1262, promotes tumour progression and forecasts the prognosis of patients in breast cancer

, , , , &
Pages 657-665 | Received 29 Oct 2019, Accepted 09 Jan 2020, Published online: 29 Jan 2020

References

  • Abd El Gwad, A. and Matboli, M., 2018. Role of exosomal competing endogenous RNA in patients with hepatocellular carcinoma. Journal of cellular biochemistry119 (10), 8600–8610.
  • Anastasiadi, Z., et al., 2017. Breast cancer in young women: an overview. Updates in surgery, 69 (3), 313–317.
  • Assadi, A.H., et al., 2003. Interaction of reelin signaling and Lis1 in brain development. Nature genetics, 35 (3), 270–276.
  • Bai, X.Q., et al., 2018. PCSK9: a potential regulator of apoE/apoER2 against inflammation in atherosclerosis? Clinica chimica acta, 483, 192–196.
  • Board, P., 2002. Male breast cancer treatment (PDQ(R)): patient version, in PDQ cancer information summaries. Bethesda, MD: National Cancer Institute (US).
  • Cuchillo-Ibanez, I., et al., 2016. The beta-amyloid peptide compromises Reelin signaling in Alzheimer’s disease. Scientific reports, 6, 31646.
  • Desreux, J., 2018. Breast cancer screening in young women. European journal of obstetrics & gynecology and reproductive biology, 230, 208–211.
  • Furuya, Y., et al., 2016. Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins. Prostate international, 4 (2), 56–60.
  • Guillaumond, F., et al., 2015. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Proceedings of the National Academy of Sciences, 112 (8), 2473–2478.
  • Harbeck, N. and Gnant, M., 2017. Breast cancer. The lancet, 389 (10074), 1134–1150.
  • Houssami, N., Turner, R.M., and Morrow, M., 2017. Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer. Breast cancer research and treatment, 165 (2), 273–283.
  • Jiang, L., et al., 2015. Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer. Oncotarget, 6 (26), 22072–22080.
  • Kadry, S. and Roufayel, R., 2019. MicroRNAs: crucial regulators of stress. MicroRNA, 08.
  • Lane-Donovan, C. and Herz, J., 2017. The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease. Journal of lipid research, 58 (6), 1036–1043.
  • Li, F., 2019. Expression and correlation of miR-124 and miR-126 in breast cancer. Oncology letters, 17 (6), 5115–5119.
  • Lin, C.C., et al., 2018. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer. Cancer letters, 438, 165–173.
  • Maire, V., et al., 2019. LRP8 is overexpressed in estrogen-negative breast cancers and a potential target for these tumors. Cancer medicine, 8 (1), 325–336.
  • Merino Bonilla, J.A., Torres Tabanera, M., and Ros Mendoza, L.H., 2017. Breast cancer in the 21st century: from early detection to new therapies. Radiología, 59 (5), 368–379.
  • O’Bryan, S., et al., 2017. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer. European journal of cancer, 72, 1–11.
  • Pencheva, N., et al., 2012. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell, 151 (5), 1068–1082.
  • Pogoda, K., et al., 2013. Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients. Medical oncology, 30 (1), 388.
  • Roslan, Z., et al., 2019. The roles of low-density lipoprotein receptor-related proteins 5, 6, and 8 in cancer: a review. Journal of oncology, 2019, 1–6.
  • Sorlie, T., et al., 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America, 98 (19), 10869–10874.
  • Tavazoie, M.F., et al., 2018. LXR/ApoE activation restricts innate immune suppression in cancer. Cell, 172 (4), 825–840.e18.
  • Tutar, L., Özgür, A., and Tutar, Y., 2018. Involvement of miRNAs and Pseudogenes in Cancer. Methods in molecular biology, 1699, 45–66.
  • Xian, X., Pohlkamp, T., and Durakoglugil, M.S., 2018. Reversal of apoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease. Elife, 7, e40048.
  • Xie, K., et al., 2017. A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in Chinese population. International journal of cancer, 141 (5), 958–966.
  • Yang, T. and Williams, B.O., 2017. Low-density lipoprotein receptor-related proteins in skeletal development and disease. Physiological reviews, 97 (3), 1211–1228.
  • Zhang, G., et al., 2009. Differential interaction of the Pafah1b alpha subunits with the Reelin transducer Dab1. Brain research, 1267, 1–8.
  • Zhang, J., et al., 2012. Ten Dijke P. LRP8 mediates Wnt/beta-catenin signaling and controls osteoblast differentiation. Journal of bone and mineral research, 27 (10), 2065–2074.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.